Despite the growing body of research on the use of biomarkers to guide asthma treatment, clinicians are still resistant to their use in daily practice, research shows. A survey of Australian members of the TSANZ Asthma Special Interest Group found only 53% of the 17 respondents were using or would like to use biomarkers to ...
Asthma biomarkers not yet fully adopted in daily practice
By Mardi Chapman
9 Jun 2020